Annenberg Center for Health Sciences
Improving Knowledge and Awareness of Preventive Antibodies for RSV Infants and Young Children
Respiratory syncytial virus (RSV) is a contagious respiratory infection and a leading cause of illness in children. This activity includes five conversations with experts in nursing, pediatrics, and neonatology. They review RSV basics, current immunoprophylaxis options, and tools to help clinicians prevent RSV in infants and young children, with detailed discussion of RSV antibodies, supporting evidence, and recommendations.
Author
Annenberg Center for Health Sciences
Category
Podcast website
Latest episode
Feb 13, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Tools to Facilitate RSV Prevention 13.02.2026 7:29
Resources for Clinicians Practical Considerations
Clinical Recommendations for RSV Prevention 13.02.2026 13:21
Organizational Guidance Infants <8 Months Infants/Young Children 8-19 Months Antibody Administration
RSV Immunoprophylaxis Strategies in Infants/Young Children 13.02.2026 15:39
Historical Use of Palivizumab Basics of RSV Antibodies Nirsevimab Clesrovimab
RSV Immunoprophylaxis Strategies in Pregnant Parents 13.02.2026 8:50
Pregnant Parent Vaccination (RSVpreF)
RSV Infection in Infants/Children 13.02.2026 16:11
Epidemiology Morbidity and Mortality Signs and Symptoms Risk Factors Acute and Chronic Complications
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.